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Chronic obstructive pulmonary disease (COPD) is a common airway disorder. In
particular, acute exacerbations of COPD (AECOPD) can significantly reduce pulmonary
function. The majority of AECOPD episodes are attributed to infections, although
environmental stress also plays a role. Increasing urbanization and associated air
pollution, especially in developing countries, have been shown to contribute to COPD
pathogenesis. Elevated levels of particulate matter (PM) in polluted air are strongly
correlated with the onset and development of various respiratory diseases. In this
review, we have conducted an extensive literature search of recent studies of the role
of PM2.5 (fine PM) in AECOPD. PM2.5 leads to AECOPD via inflammation, oxidative
stress (OS), immune dysfunction, and altered airway epithelial structure and microbiome.
Reducing PM2.5 levels is a viable approach to lower AECOPD incidence, attenuate COPD
progression and decrease the associated healthcare burden.
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INTRODUCTION
According to the most recent Global Initiative for Chronic Obstructive Lung Disease (GOLD)
guidelines, COPD is defined as “a common preventable and treatable disease” characterized by
“persistent airflow limitation that is usually progressive and associated with enhanced chronic
inflammatory response in the airways and the lung to noxious particles and gases” (GOLD, 2015).
Conservative estimates of COPD incidence hover around 210 million cases worldwide, excluding
those that are under-recognized or under-diagnosed (Soriano and Lamprecht, 2012). As reported
by the World Health Organization (WHO), it is estimated that COPD is poised to become the
third largest leading cause of death in the world by 2020 (GOLD, 2015). Due to its high morbidity
and mortality, COPD imposes a significant economic burden, contributing to a direct cost of $29.5
billion and an indirect cost of $20.4 billion in the United States annually (National Heart, Lung,
and Blood Institute, 2009).
The exacerbation phase of COPD, known as AECOPD, is associated with symptoms such as
increased dyspnea, cough, sputum and/or purulent sputum production (GOLD, 2015). AECOPD
reduces respiratory function and negatively affects disease progression and prognosis, leading
to high healthcare costs (McGuire et al., 2001). Nevertheless, the management of AECOPD
remains a clinical challenge. Currently, AECOPD pathogenesis can be attributed to infectious
Abbreviations: COPD, chronic obstructive pulmonary disease; AECOPD, acute exacerbation of COPD; PM, particulate
matter; OS, oxidative stress; ROS, reactive oxygen species; AM, alveolar macrophage; DEP, diesel exhaust particle.
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and non-infectious factors. Specifically, bacterial and viral
infections are the most prevalent causes of AECOPD (Perotin
et al., 2013). In the sputum of 40–60% of AECOPD patients,
bacteria such as Haemophilus influenzae, Moraxella catarrhalis,
and Streptococcus pneumoniae can be detected. In addition,
airway viral infections, including rhinovirus, respiratory syncytial
virus (RSV) and influenza virus may contribute to AECOPD
pathogenesis (Perotin et al., 2013).
Non-infectious factors, mainly atmospheric pollution, are also
implicated in AECOPD. Notably, inhalable particulate matter
(PM), which is a major player in air pollution, is involved in
various chronic airway inflammatory diseases. Recent studies
have demonstrated that PM2.5 (aerodynamic diameter≤ 2.5µm)
is closely correlated with AECOPD morbidity and mortality
(Sarnat et al., 2001; Dominici et al., 2003; Laden et al., 2006).
For instance, Li et al. reported that a 10µg/m3 increase in
atmospheric PM2.5 raised the total mortality of COPD by 2.5%
in cities worldwide (Li et al., 2015). PM2.5 induces AECOPD
through a variety of mechanisms, including oxidative stress (OS),
airway inflammation, airway epithelial damage, and inhibition
of local airway immunity (Ling and van Eeden, 2009). In
this review, we performed a systematic search of PubMed and
Medline from 2000 to 2015 for literature related to the role of
PM2.5 in AECOPD pathogenesis. We aim to investigate PM2.5
involvement in AECOPD and the significance of managing air
pollution in preventing exacerbations of COPD.
PM2.5 STRUCTURE AND COMPOSITION
PM refers to the dispersed solid, liquid or solid-liquid
suspensions in the air (Wilson et al., 2002). The diameter,
composition, and origin of PM play an important role in
toxicity and biological pathogenicity (Valavanidis et al., 2008).
PM measuring greater than 10µm in diameter can be trapped
in the mucus lining within the nose and respiratory tract, and
can be readily eliminated through normal breathing activities
(Squadrito et al., 2001). However, PM with a diameter less than
10µm ismore difficult to remove from the respiratory tract when
inhaled (Squadrito et al., 2001). In particular, PM2.5 (also known
as the fine particulate) reaches distal airways and deposits in
alveolar regions (Squadrito et al., 2001). The soluble components
of PM2.5 may enter the blood circulation through alveolar
capillaries as ultrafine PM, whereas the insoluble portions
sediment in the lung, thereby leading to detrimental health
outcomes including airflow obstruction (Ling and van Eeden,
2009; Brook et al., 2010). Consequently, PM2.5 is commonly
associated with cardiovascular diseases and chronic airway
diseases, such as COPD and atherosclerosis. A tendency for
PM to accumulate in the centribular emphysematous lesion and
induce persistent inflammation has suggested its association with
COPD pathogenesis, characterized by emphysema (Ling and van
Eeden, 2009). Accordingly, Bose et al. showed the correlations
between indoor PM2.5 and systemic inflammation in COPD
patients. Yet such relationship was not found with coarse fraction
of particles (PM2.5−10) (Bose et al., 2015).
The extent of PM2.5 deposition in the lung is determined
by the inhaled concentration, tissue structure, and the clearing
ability of airway cilia. COPD patients with persistent airway
obstruction and abnormal lung architecture may display higher
levels of PM2.5 pulmonary deposits when compared with healthy
individuals (Ling and van Eeden, 2009). The resulting damage to
airway cilia and the reduced ability to perform airway clearance
prevent the timely elimination of PM2.5 from the airway and
lungs (Ling et al., 2011). In a polluted environment, each
alveolus comes in contact with an average of 1500 particulate
molecules in a 24 h period. Approximately 50% of the PM
deposits occur in the alveolus, of which 96% are composed of
PM2.5 (Valavanidis et al., 2008). Further, the generation of PM2.5
is primarily attributed to industrial combustion, traffic emission,
and agricultural activities (Laden et al., 2000; Saliba et al., 2010).
Its chemical composition varies with different environmental
sources.
PM2.5 as a Carrier
The characterization of PM2.5 chemical composition reveals
its toxicity, which is relevant to the adverse health effects
imposed by PM2.5 (Bell et al., 2007). PM2.5 may absorb
organic molecules, transition metals, reactive gases, microbial
components, and minerals, serving as a carrier for these
potentially harmful molecules (Kleeman et al., 2000; Sillanpaa
et al., 2006). In particular, Bell et al. have found that several
components, including chlorine, zinc, and bromide, showed
strong seasonal correlations; that is, higher concentration of these
components were detected in PM2.5 during winter (Bell et al.,
2007).
Iron is a transient metal that is commonly found in PM2.5.
Soluble metal ions absorbed by PM2.5 are considered a key factor
in the impairment of lung cell. Redox-active metals trigger a
series of catalytic reactions and free radical formation, leading
to lipid peroxidation in the cell membrane and inflammation
(Harrison and Yin, 2000; Meng and Zhang, 2006; Schwarze
et al., 2006). PM2.5 containing higher levels of heavy metals
may damage the macrophages, leading to reduced phagocytosis
(Zhou and Kobzik, 2007). Zhou and Kobzik reported that the
chelation of iron substantially reversed its toxicity to macrophage
cells (Zhou and Kobzik, 2007). Iron attached to the surface of
particulate can disturb redox balance by inducing the release
of hydroxyl radicals, further damaging DNA and generating
an OS marker 8-hydroxy-2-deoxyguanine (8-OHdG) (Knaapen
et al., 2002). High levels of soluble metal zinc in PM have
been shown to increase the levels of neutrophils, macrophages
and protein in mouse bronchoalveolar lavage (BAL) (Adamson
et al., 2000). Adamson et al. also detected focal fibrosis in
the alveolar mesenchyme, which demonstrated that zinc in
PM2.5 was related to chronic or acute pulmonary inflammation
(Adamson et al., 2000). Furthermore, Dergham et al. reported
that the transient metals, as well as organic chemicals, attached
to PM2.5 to upregulate the gene expression of xenobiotic-
metabolizing enzymes, cytochrome P4501a1 and 1b1 in human
bronchial epithelial cells (Dergham et al., 2012).
The biological components of PM2.5 are potentially involved
in the activation of pulmonary immunity (Alexis et al., 2006).
Specially, Alexis et al. observed an up-regulation of TNF-
α mRNA expression solely in the non-heat-treated PM2.5−10
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group (Alexis et al., 2006). During the lipopolysaccharide (LPS)-
mediated immune reaction, the expression of mCD14 on the
surface of macrophages is higher in the non-heat-treated group
than in the heat-treated group (Alexis et al., 2006). It is
shown that heat treatment inactivates heat-sensitive biological
components on the surface of PM2.5 such as LPS (from gram-
negative bacteria) and the peptidoglycans (from gram-positive
bacteria) (Alexis et al., 2006).
PM2.5 AND AIRWAY INFLAMMATION IN
COPD
Exacerbation of airway inflammation is a key feature in
AECOPD (Figure 1). Indeed, inflammatory biomarkers such
as tumor necrosis factor alpha (TNF-α), interleukin (IL)-6
and IL-8 were significantly elevated in the induced sputum
of AECOPD patients, while the concentrations returned to
lower values during the recovery (Bhowmik et al., 2000; Aaron
et al., 2001). PM2.5 enhanced airway inflammation via any
of the following mechanisms (Figure 1): (1) Release of pro-
inflammatory cytokines (e.g., TNF-α and IL-1) and oxygen
radicals due to active phagocytosis of PM2.5 mainly by alveolar
macrophages (AMs); (2) Production of chemoattractive and
pro-inflammatory mediators, such as granulocyte macrophage
colony-stimulating factor (GM-CSF), by lung epithelial cells
results in enhanced leukocyte recruitment; (3) Generation of
oxygen free radicals and proteases from the damaged alveolar
epithelial or immune cells (Ling and van Eeden, 2009; Valavanidis
et al., 2013).
Immune cells, such as AMs, directly interact with PM2.5,
playing an important role in the elimination of inhaled
particulate. As mentioned previously, PM2.5 may stimulate AM
to release inflammatorymediators such as arachidonic acid (AA),
TNF-α and IL-6, leading to airway inflammation (Table 1; Pozzi
et al., 2003). In addition, PM2.5 has been shown to compromise
the functional capacity of phagocytic cells and influence the
expression of these cells (Ling and van Eeden, 2009). Exhaled
nitric oxide (FeNO), an indicator of airway inflammation, is
positively correlated with the number of airway inflammatory
cells. Notably, the ambient air pollution-induced PM2.5 leads to
increased FeNO levels in the elderly (Adamkiewicz et al., 2004).
In a study with healthy, nonsmoking subjects, an increase in
sputum neutrophils was observed after 4 h exposure to diesel
exhaust particle (DEP) (Nightingale et al., 2000). Levels of
inflammatory factors, including TNF-α, IL-1β, IL-6, and IL-
8, were significantly elevated after PM2.5 exposure to human
bronchial epithelial cells (Cachon et al., 2014).
PM2.5 initiates a series of genetic mechanisms via nuclear
factor kappa-light-chain-enhancement of activated B cells (NF-
κB) thereby leading to a reaction cascade involving cytokine
release (Dagher et al., 2007). PM2.5-induced epithelial OS
facilitates the binding of NF-κB to DNA resulting in increased
mRNA expression of NF-κB-related downstream inflammatory
cytokines such as TNF-α, TNF-β, and IL-6 (Shukla et al., 2000).
These inflammatory cytokines further increases inflammatory
cell infiltration and airway mucus secretion, thereby aggravating
airway stenosis and breathing difficulty (Shukla et al., 2000).
Additionally, the metals in PM2.5 trigger human bronchial
FIGURE 1 | This schematic summarizes the role of PM2.5 in AECOPD. PM2.5, particulate matter ≤ 2.5µm; OS, oxidative stress; COPD, chronic obstructive
pulmonary disease; AECOPD, acute exacerbations of COPD.
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TABLE 1 | A summary of PM2.5 involvement in AECOPD pathogenesis.
Potential contributing Effects induced by PM2.5 References
factors of AECOPD
Inflammation Airway inflammation • Neutrophil recruitment to the sputum Nightingale et al., 2000
• Stimulate AM to release AA, TNF-α and IL-6 Pozzi et al., 2003
• NF-κB activation
• Elevated inflammatory cytokines
Shukla et al., 2000; Maciejczyk et al., 2010;
Cachon et al., 2014
Systemic inflammation • Release of white blood cell and platelets Tan et al., 2000; van Eeden and Hogg, 2002
• Pro-thrombotic effects
• Higher risk of cardiopulmonary events
Mills et al., 2005; Lucking et al., 2008
Oxidative stress • Airway epithelium-associated OS Shukla et al., 2000; Baulig et al., 2003
• Increment of OS metabolites (e.g., 8-isoprostane)
and lipid peroxidation (e.g., TBARS)
• Reduced GSH and SOD activities
Meng and Zhang, 2006; Riva et al., 2011
• Redox disruption by transient metals found in PM2.5
• Oxidative DNA damage
• Reduced phagocytosis due to impaired
macrophages
Aust et al., 2002; Knaapen et al., 2002; Zhou
and Kobzik, 2007
• Mitochondrial dysfunction Upadhyay et al., 2003; Gualtieri et al., 2009;
Wu et al., 2013
Altered immunity and
susceptibility to infection
Bacterial infection • Suppressed phagocytosis of bacteria Lundborg et al., 2006; Zhou and Kobzik,
2007
• Increased pneumococcal adhesion to epithelial cells Mushtaq et al., 2011
• Decreased TLR expressions and impaired
antibacterial efficacy
Becker et al., 2005
Viral infection • Reduced SP-A and CCSP production Wang et al., 2003
• Enhanced viral adhesion and invasion Castranova et al., 2001; Jaspers et al., 2005
AA, arachidonic acid; AM, alveolar macrophage; CCSP, clara cell secretory protein; GSH, glutathione; IL-6, interleukin 6; NF-κB, nuclear factor kappa-light-chain-enhancer of activated
B cells; OS, oxidative stress; SOD, superoxide dismutase; SP-A, surfactant protein A; TBARS, thiobarbituric acid reactive substances; TLR, toll-like receptor; TNF-α, tumor necrosis
factor alpha.
epithelial cells to release proinflammatory cytokines via NF-
κB activation. PM2.5 also induces elevated gene expression of
intercellular adhesion molecules, resulting in the adhesion of
epithelial and inflammatory cells (Table 1; Maciejczyk et al.,
2010).
Systemic inflammation is highly associated with the incidence
and progression of COPD (Groenewegen et al., 2008). The
levels of blood inflammatory markers, such as c-reactive protein
(CRP), fibrinogen, and TNF-α, have been shown to elevate in
stable COPD (Gan et al., 2004; Karadag et al., 2008). Whether
inhaled PM2.5 can directly integrate into systemic circulation
still remains a controversy (Brown et al., 2002; Kreyling et al.,
2002; Nemmar et al., 2002). PM2.5 contributes to the systemic
inflammatory response and the functional alteration of multiple
organs (van Eeden et al., 2005). PM2.5 exacerbates COPD
systemic inflammation via: (1) activation of inflammatory cells
and related inflammatory mediators that infiltrate into the
systemic circulation through lung tissue; (2) stimulation of
hepatic synthesis of CRP and fibrinogen; (3) stimulation of
bone marrow function leading to increased white blood cell
and platelet counts; and (4) damaged endothelial system and
increased cardiovascular morbidity and mortality (van Eeden
and Hogg, 2002; van Eeden et al., 2005).
PM2.5, Airway Immunity, and Infection
The relationship between PM2.5 and airway immune function
is complex. PM2.5 activates innate immunity and amplifies
inflammatory reactions. For example, PM2.5 stimulates airway
epithelial cells to secrete the chemokine MIP-3α (CCL20),
thereby recruiting dendritic cells (DC) to airways (Reibman
et al., 2003). In addition, DEP up-regulates the co-stimulatory
molecules (CD40 and CD86) and facilitates T helper 2 (Th2)-
mediated immune response (van Zijverden et al., 2000). The
expression of MHC class II molecule was also up-regulated by
DEP exposure (Inoue et al., 2009). Interestingly, DEP exposure
prior to viral infection increases the expression of the toll-like
receptor 3 (TLR 3) and pro-inflammatory cytokines in human
pulmonary epithelial cells, thus enhancing the innate immunity
(Ciencewicki et al., 2006). PM2.5 exposure alters the distal airway
microbiome of COPD patients, and diminishes its ability to
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resist microbial infection by suppressing the function of immune
cells (Figure 1). An elevation of PM2.5 level leads to enhanced
hospitalization for pneumonia (Tsai and Yang, 2014). According
to the study of Matthews et al. PM2.5 in urban areas may inhibit
the generation of primary T helper type 1 (Th1) cell and reduce
the levels of IFN-γ, IL-5, and IL-13, which compromises IFN-
γ-mediated antibacterial and antiviral immunity in the lungs
(Matthews et al., 2014).
As the first line of host defense in the lungs, AMs are primarily
responsible for eliminating harmful microorganisms and inhaled
foreign particles, playing an important role in innate immunity
(Nicod, 2005). Zhou et al. studied the impact of concentrated
ambient particles (CAPs) on murine macrophage cell lines.
The results indicated that CAPs suppress the internalization of
S. pneumoniae by macrophages (Zhou and Kobzik, 2007). In
addition, several studies showed that exposure to PM2.5 impairs
the phagocytic capacity of human AM (Lundborg et al., 2006; Xu
et al., 2008). Becker et al. found that PM2.5 exposure decreased
the expression of phagocytosis-related receptor, CD11b, on the
surface of AM, although to a lesser extent compared with PM10
(Becker et al., 2003). These studies demonstrated that PM2.5
reduced the functional airway defenses when combating viruses,
bacteria and other microorganisms by inhibiting the phagocytic
function of AM.
Further, PM2.5 also affects the function of circulating
immune cells. Acute PM exposure stimulates polymorphonuclear
leukocytes (PMN)-associated respiratory burst, and superoxide
dismutase (SOD) supplementation may diminish such an
effect (Marchini et al., 2014). Oxidative DNA damage of the
lymphocytes has been reported to significantly associate with
transitionmetal-rich PM2.5 (Sørensen et al., 2005). Fujimaki et al.
studied the adjuvant impact of DEP on systemic IgE generation
in an ovalbumin (OA)-treated mouse model. The experimental
group of mice was administered DEP and OA, an antigen that
induces allergic pulmonary responses (Fujimaki et al., 2001).
After immunization, levels of serum anti-OA IgE antibody were
markedly higher in the experimental group than those in the
control group treated with OA only. The result indicated that
exposure to DEP was responsible for the increased systemic IgE
response to OA (Fujimaki et al., 2001). PM2.5 is related to airway
hyperresponsiveness and systemic IgE response (Ogino et al.,
2014). Asthma-COPD overlap syndrome (ACOS), one of the
clinical phenotypes of COPD, shows evidence of both airway
hyperresponsiveness and fixed airflow obstruction (Zeki et al.,
2011). Thus, PM2.5 exposure and high levels of serum IgE are risk
factors for acute exacerbation of ACOS.
In healthy populations, lower portions of the airways remain
aseptic. However, bacterial colonization is commonly observed
in the lower airway of stable COPD as well as other chronic lung
diseases. Indeed, a higher prevalence of pathogenic infection and
altered lung defense have been implicated in exacerbated COPD
(Patel et al., 2002; Sethi et al., 2002). Potentially pathogenic
bacteria (PPB) present in the BAL fluid include: S. pneumoniae,
Moraxella catarrhalis, Haemophilus influenza, and Pseudomonas
aeruginosa. The colonization by PPB is closely related to chronic
airway inflammation in COPD (Sethi et al., 2006). PM2.5
increases the risk of bacterial infections in COPD patients via
several mechanisms. Researchers found that PM2.5 particles carry
bacteria and bacteria-derived components (Menetrez et al., 2001;
Alghamdi et al., 2014). Therefore, they may alter the microbiome
in the distal airway of COPD patients and subsequently lead to
AECOPD (Figure 1). Another study demonstrated that PM2.5
exposure promoted pneumococcal adhesion to human epithelial
cells, thereby enhancing pneumococcal pneumonia susceptibility
(Table 1; Mushtaq et al., 2011). In addition, suppression of
pulmonary immune function is one of the primary factors
leading to bacterial infections. The carbonaceous core of DEP
absorbs multiple organic materials such as PAH and transient
metals. DEP is more likely to be inhaled into lower airways and
alveolar tissues (Castranova et al., 2001; Yanagisawa et al., 2003).
DEP diminishes pulmonary antimicrobial ability, increasing the
susceptibility to infection. PM2.5 reduces bacterial elimination
from the lungs via suppressed production of LPS-stimulated
proinflammatory cytokines, such as IL-1 and TNF-α, and
weakened phagocytosis (Castranova et al., 2001). PM2.5 decreases
the expression of toll-like receptors and suppresses TNF and IL-
8 release in AM (Table 1), impairing the antibacterial efficacy of
the respiratory system (Becker et al., 2005).
Moreover, Listeria monocytogenes (L. monocytogenes) is a
common gram-positive, facultative anaerobic bacterium. AMs
and neutrophils are effector cells that can eliminate L.
monocytogenes (Yang et al., 2001). Yang et al. observed that
DEP reduces the responsiveness of AM to L. monocytogenes
and its ability to secret antimicrobial oxidants, such as nitric
oxide, thus impairing the airway cleaning competence (Yang
et al., 2001). Moreover, IL-12 plays an important role in Th1 cell
anti-L. monocytogenes infection’s immune response. Researchers
found that DEP decreases cell-mediated immune responses upon
L. monocytogenes infection via AM-secreted IL-12 suppression
(Yin et al., 2002). S. pneumoniae infection and sepsis are one
of the most common factors for increased hospitalization in
the elderly above the age of 70 (Marrie, 2000). S. pneumoniae
is also a common pathogenic bacterium of AECOPD (Pérez-
Trallero et al., 2011). Epidemiological studies have shown that
air pollution increases the vulnerability to bacterial pneumonia
(Medina-Ramón et al., 2006; Neupane et al., 2010). Zelikoff et al.
established rat models through intratracheal instillation of S.
pneumoniae and observed the impact of PM2.5 on the pulmonary
antibacterial immune function. The results demonstrated that
rats exposed to PM2.5 had decreased levels of PMN in BAL fluid
(Zelikoff et al., 2003). In addition, the expression of inflammatory
mediators such as TNF-α and IL-1 associated with mobilization
and activation of PMN, was all decreased (Zelikoff et al., 2003).
The mortality of PM2.5-exposed group was significantly higher
than air-exposed control rats. The study revealed that PM2.5
exposure may increase the severity of bacterial infections by
inhibiting the host anti-microorganism immunity (Zelikoff et al.,
2003).
PM2.5 exposure can increase the risk of respiratory viral
infections (Wang et al., 2003). Surfactant protein A (SP-A)
and clara cell secretory protein (CCSP) are both important
components of innate immune defense mediators for antiviral
respiratory infection (Wang et al., 2003; Derscheid and
Ackermann, 2013). Harrod et al. found that DEP-exposed mice
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have significantly higher gene expression of RSV in lung tissues
than control mice (Wang et al., 2003). In addition, the number
of inflammatory cells in BAL fluid of both RSV-infected and
uninfected mice that were exposed to high-level DEP, was
increased (Wang et al., 2003). Lung histopathology examination
revealed airway epithelial remodeling with the loss of the normal
appearance of bronchial epithelium, and mucous cell metaplasia.
Levels of airway epithelium CCSP production and the SP-A
secretion in the DEP group were both reduced (Table 1; Wang
et al., 2003). These results suggest that DEP exposure can decrease
lung immune defenses against viruses. Likewise, Lambert et al.
observed a reduced expression of IFN-γ, a cytokine essential
for microbial defenses, in RSV-infected mice preexposed to
ultrafine particles, suggesting increased body’s susceptibility to
RSV upon PM2.5 exposure (Lambert et al., 2003). Additionally,
DEP exposures can increase the number of infected A549
cells by enhancing OS, the ability of adhesion and invasion
of the influenza virus (Jaspers et al., 2005). DEP promotes
the replication of the influenza virus in the lungs through the
inhibition of antiviral interferon production (Table 1; Castranova
et al., 2001). These results support that PM2.5 can increase the
susceptibility to the influenza virus in airway epithelial cells.
PM2.5, OXIDATIVE STRESS, AND AECOPD
The chronic inflammatory reaction and OS in COPD are
not limited to the lungs. Instead, systemic oxidant-antioxidant
imbalance and low-grade systemic inflammation are observed in
COPD (Donaldson et al., 2005; van Eeden et al., 2005). During
normal metabolic processes, ROS are formed constantly in the
cells (Zuo et al., 2013). Particularly in COPD development, ROS
are released excessively by leukocytes, such as macrophages,
in the airway due to the enhanced phagocytosis of exogenous
molecules. Impaired alveolar epithelial cells also contribute to the
elevated level of ROS. Subsequently, the endogenous antioxidants
are unable to neutralize overproduced ROS thereby leading to OS
(Zuo et al., 2014).
AECOPD patients exhale higher levels of 8-isoprostane in
the lungs, indicating pulmonary OS (Biernacki et al., 2003).
Several studies have suggested that some components of PM2.5,
such as transient metals, polycyclic aromatic hydrocarbon
(PAH) and carbonaceous material stimulate ROS release from
pulmonary epithelial cells. PM2.5-induced ROS generation, such
as superoxide and hydrogen peroxide, further damage cilia and
contribute to mucus hypersecretion, airway stenosis and dyspnea
(Dagher et al., 2007; Gualtieri et al., 2010; Seriani et al., 2015).
Riva et al. reported that a small dose of PM2.5 causes functional
and histological lung damage inmousemodels. Mice treated with
intranasal instillation of PM2.5 suspension showed an increased
resistance in lung ventilation and a decrease in tissue elasticity
(Riva et al., 2011). A pathological examination revealed alveolar
collapse and lung biochemical analysis indicated increased
neutrophil activity (Riva et al., 2011). Increased OS metabolites,
such as 8-isoprostane and thiobarbituric acid, accompanied by
elevated catalase activity and a reduction in GSH/GSSG, were
also observed (Riva et al., 2011). Accordingly, a dose-dependent
decrease of GSH levels and SOD activities was seen in rat
lungs exposed to fine particles in a dust storm. The level of
thiobarbituric acid reactive substances (TBARS) also increased
along with fine particle exposure, indicating the occurrence of
lipid peroxidation (Table 1; Meng and Zhang, 2006). Cytokines
such as IL-6 and IL-1β induced by ROS/inflammation enter
the blood circulation and stimulate liver cells to produce acute
phase proteins (e.g., CRP and fibrinogen). As a result, additional
systemic inflammation and cardiovascular events are prompted
(van Eeden et al., 2005). Meng and Zhang studied the impact of
fine particles from a dust storm on systemic OS in a rat model.
After 24 h of PM2.5 exposure, the antioxidants SOD and GSH
were significantly decreased within the lung and liver tissues.
TBARS, the biomarkers of endogenous lipid peroxidation,
increased in the lungs, heart, and liver demonstrating that PM2.5
not only affected the lungs, but also caused systemic OS (Meng
and Zhang, 2006).
As the first line of defense, airway epithelial cells are most
susceptible to the toxicity of PM2.5. Specifically, the damaged
epithelium is known to release ROS and inflammatory mediators
(Baulig et al., 2003). In an in vitro study, which examined
the impact of PM2.5 on epithelial lung A549 cells, Deng et al.
found that these cells release lactate dehydrogenase (LDH),
produce ROS, and reduce intracellular levels of SOD and
catalase. PM2.5-exposed A549 cells also showed an up-regulation
of autophagy-related protein markers, such as microtubule-
associated protein light chain-3 (LC3), Atg5, and Beclin in both
time- and concentration-dependent manner (Deng et al., 2013).
These results suggest that PM2.5 may damage the lung tissue and
impair lung function through epithelial cells autophagy induced
by OS. PM2.5 significantly induced the mRNA expression of pro-
apoptotic genes such as p53 and Bax, while decreasing the mRNA
expression of anti-apoptotic genes, such as Bcl-2 in human
epithelial lung L132 cells. As a result, PM2.5 caused apoptosis of
L132 via multiple pathways related to OS (Dagher et al., 2006).
PM2.5 may generate a toxic effect in lung epithelium via
oxidative damage in the mitochondria (Table 1). Upadhyay et al.
reported that airborne PM causes mitochondrial dysfunction
in A549 cells via iron-derived free radicals. Reduction in
mitochondrial membrane potential and caspase-9 activation was
detected in the study (Upadhyay et al., 2003). Alterations in
membrane integrity, permeability, and mitochondrial structure
result in epithelial cell damage (Gualtieri et al., 2009; Wu
et al., 2013). In human epithelial lung cells (L132), PM2.5
has been attributed to the elevation of OS markers such as
malondialdehyde (MDA) (Garçon et al., 2006). PM2.5 also
promotes the secretion of TNF-α, inducible nitric oxide synthase
(iNOS), and nitric oxide (NO) in a dose- and time-dependent
manner (Garçon et al., 2006). Further, PM2.5 causes endothelial
damage by inducing inflammatory response (Montiel-Davalos
et al., 2010). Moreover, Nurkiewicz et al. observed increased
LDH activities and albumin protein levels in the experimental
rat groups exposing to PM2.5 (residual oil fly ash; mean diameter
2.2µm) (Nurkiewicz et al., 2004).
COPD patients often develop other systemic diseases,
including heart disease, degeneration of skeletal muscle function,
malnutrition, osteoporosis, diabetes, and depression (Chatila
et al., 2008). Cardiovascular diseases such as atherothrombotic
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disease, pulmonary hypertension, and chronic congestive heart
failure, are commonly found in COPD subjects (Sin and Man,
2003; van Eeden et al., 2005). Inflammatory mediators, such
as TNF-α, IL-6, IL-1β, and GM-CSF, impair endothelium and
elevate white blood cell counts (van Eeden et al., 2005). There
were increased levels of PMN as well as leukocyte rolling and
adhesion in the microvascular walls (Nurkiewicz et al., 2004).
PM2.5 exposure may aggravate cardiac afterload by increasing
peripheral arterial pressure (Vincent et al., 2001; Nurkiewicz
et al., 2004). Epidemiological studies showed that PM2.5 is tightly
related to cardiovascular incidence and hospitalization (Le Tertre
et al., 2002; Dominici et al., 2006). For example, the increased
hospital admissions for heart failure is considered to be associated
with short-term exposure of PM2.5 (Dominici et al., 2006).
A multi-country epidemiological study demonstrated that an
increase of 10µg/m3 in PM2.5−10 size, was associated with a
0.76% increase in cardiovascular deaths and 0.58% in respiratory
deaths (Analitis et al., 2006). A study using an animal model
showed that short-term exposure to PM2.5 causes OS damage in
both cardiac and pulmonary tissues (Gurgueira et al., 2002).
Studies have also indicated that systemic inflammation
is induced by atmospheric pollution and inhaled PM may
stimulate bone marrow to release white blood cells and blood
platelets. This can increase blood viscosity, which promotes
inflammatory responses and impairments in both pulmonary
and cardiovascular tissues (Tan et al., 2000; van Eeden and Hogg,
2002). Since cardiac and pulmonary functions are interrelated,
cardiovascular issues may contribute to AECOPD complications.
Zuo et al. demonstrated that DEP induces NADPH oxidase-
dependent ROS production in a diabetic model of rat
cardiomyocyte, thereby exacerbating contractile dysfunction.
Such adverse effect can be attenuated by the co-culture
with antioxidants (Zuo et al., 2011a,b). Thrombotic events,
especially deep vein thrombosis and pulmonary embolisms,
are one of the frequent inducing factors and complications
of AECOPD (Erelel et al., 2002). There are several ways
that PM2.5 can alter hemostasis. By utilizing hamster models,
Nemmar et al. reported that inhaled DEP can trigger platelet
activation and aggregation, promoting thrombus formation
(Nemmar et al., 2004). Likewise, the study on human subjects
revealed that PM2.5 demonstrates pro-thrombotic effects through
suppressing tissue plasminogen activator release and impairing
endogenous fibrinolysis (Table 1; Mills et al., 2005; Lucking
et al., 2008). Therefore, exposure to PM2.5 can trigger acute
myocardial infarction and atherothrombosis. From the data
analysis of Third National Health and Nutrition Examination
Survey (NHANES III), researchers found that air pollution
is responsible for increased white cell counts, platelet counts,
and fibrinogens. These increased inflammatory cells and
mediators may potentially lead to higher blood viscosity, further
contributing to adverse cardiovascular outcomes (Schwartz,
2001).
CONCLUSION
Although the etiology and pathogenesis of AECOPD have not
been fully elucidated, studies have shown that air pollution and
PM2.5 exposure are closely related to AECOPD. PM2.5 induces
both pulmonary and systemic OS and inflammation, affecting
the patient’s respiratory and immune function, respiratory
microbiome, as well as cardiovascular system. Understanding the
mechanisms of PM2.5-induced AECOPD contributes to patient
risk management, which may reduce the likelihood of acute
exacerbations.
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